US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco S&P 500 Equal Weight Health Care ETF

37.59

+0.63001.70%

Post-market: 37.590.00000.00%19:30 EDT

Volume:166.37K

Turnover:6.25M

Market Cap:897.27M

PE:- -

High:37.65

Open:37.00

Low:37.00

Close:36.96

52wk High:38.19

52wk Low:29.46

Shares:23.87M

Float Shares:23.87M

Volume Ratio:0.69

T/O Rate:0.70%

Dividend:0.22

Dividend Rate:0.59%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

TRex Bio indicated to open at $14.50, IPO priced at $14

Teva announces FDA approval for Weltruza

Contec Medical Systems Secures Medical Device Registration Certificate for Color Doppler Ultrasound Diagnostic System

Citi Lowers Novo Nordisk Price Target to DKK 296: Oral Weight-Loss Pill Sales Outlook Improves, but Margin Growth Remains Weak

Island Pharmaceuticals Expands Unquoted Employee Options Pool

Linical Wins $20 Million U.S. Biotech Order as FDA Environment Normalizes

Health Care Down as Michigan Files Suit Against Insurer

Starbucks Explored Acquisition of Chipotle in Bid to Create Restaurant Industry Mega-Merger

Shandong Oriental Ocean's Subsidiary Secures Medical Device Registration Certificate for Water-Soluble Vitamin Assay Kit

Beijing Strong Biotechnologies Secures Medical Device Registration Certificates for Five Products

Centinel Spine Reports 42% Revenue Surge and Return to Profit as It Pursues U.S. IPO, Testing Valuations for Innovative Medical Devices

Novartis announces FDA approval of Rhapsido for symptomatic dermographism

Novartis Rhapsido® (remibrutinib) receives FDA approval as first treatment for symptomatic dermographism (SD), expanding its use beyond chronic spontaneous urticaria (CSU)

Adherium Secures Non-Dilutive AUD$700,000 Loan to Support Working Capital

Press Release: Celcuity Appoints David Gryska to Its Board of Directors

Abogen announces licensing, option agreement with Novartis

Nanobiotix taps veteran biotech CFO Arnd Christ to steer next growth phase

Oxford BioDynamics Extends Vulpes Payment Deadline in £9.15m Placing

Outlook submits HCPCS Level II application to CMS for J-code for LYTENAVA

Paramount Names Kreiz as Co-CEO as Warner Bros. Deal Nears Completion

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/RSPH/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"RSPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RSPH\",,,,,undefined,":{"symbol":"RSPH","market":"US","secType":"STK","nameCN":"Invesco S&P 500 Equal Weight Health Care ETF","latestPrice":37.59,"timestamp":1791576000000,"preClose":36.96,"halted":0,"volume":166367,"hourTrading":{"tag":"盘后","latestPrice":37.59,"preClose":37.59,"latestTime":"19:30 EDT","volume":31,"amount":1165.0542,"timestamp":1791588606096,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.017045454545454614,"floatShares":23870000,"shares":23870000,"eps":0,"marketStatus":"Closed","change":0.63,"latestTime":"10-09 16:00:00 EDT","open":37,"high":37.65,"low":37,"amount":6245932.9177,"amplitude":0.017587,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":5,"adr":0,"exchange":"ARCA","adjPreClose":36.96,"sharesOutstanding":23410000,"nav":36.98074,"aum":875334115.8,"dividendRate":0.005901,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":36.96,"preClose":36.96,"latestTime":"07:58 EDT","volume":18,"amount":665.28,"timestamp":1791547121575,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":37.59,"preClose":37.59,"latestTime":"19:30 EDT","volume":31,"amount":1165.0542,"timestamp":1791588606096,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.689614,"impliedVol":0.0046,"impliedVolPercentile":0.0797},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RSPH\",,,,,undefined,":{"symbol":"RSPH","floatShares":23870000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.689614,"shares":23870000,"dividePrice":0.2218,"high":37.65,"amplitude":0.017587,"preClose":36.96,"low":37,"week52Low":29.46,"pbRate":"--","week52High":38.19,"institutionHeld":0,"latestPrice":37.59,"eps":0,"divideRate":0.005901,"volume":166367,"delay":0,"ttmEps":0,"open":37,"prevYearClose":31.85,"prevWeekClose":36.62,"prevMonthClose":37.01,"prevQuarterClose":37.01,"fiveDayClose":36.62,"twentyDayClose":36.08,"sixtyDayClose":34.33},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RSPH\",params:#limit:5,,,undefined,":[{"date":"2026-09-21","symbol":"RSPH","amount":0.05159,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-21","defaultRemindTime":1789997400000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-25","payableDate":"2026-09-21","currency":"USD","dateTimestamp":1789963200000,"payDate":"2026-09-25"},{"date":"2026-06-22","symbol":"RSPH","amount":0.06267,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"RSPH","amount":0.05609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"RSPH","amount":0.05305,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"RSPH","amount":0.05991,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RSPH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.174967,"currency":"USD"},{"executeDate":"2023-06-20","recordDate":"2023-06-21","paymentDate":"2023-06-23","value":0.51083,"currency":"USD"},{"executeDate":"2023-09-18","recordDate":"2023-09-19","paymentDate":"2023-09-22","value":0.04794,"currency":"USD"},{"executeDate":"2023-12-18","recordDate":"2023-12-19","paymentDate":"2023-12-22","value":0.04988,"currency":"USD"},{"executeDate":"2024-03-18","recordDate":"2024-03-19","paymentDate":"2024-03-22","value":0.04585,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RSPH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RSPH\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2674686768","title":"TRex Bio indicated to open at $14.50, IPO priced at $14","url":"https://stock-news.laohu8.com/highlight/detail?id=2674686768","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674686768?lang=en_us&edition=fundamental","pubTime":"2026-10-09 22:45","pubTimestamp":1791557133,"startTime":"0","endTime":"0","summary":"TRex Bio (TRXB), a clinical-stage biotechnology company focused on tissue Treg biology for the discovery and development of immunoregulatory medici...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/trex-bio-indicated-to-open-at-14-50-ipo-priced-at-14-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/trex-bio-indicated-to-open-at-14-50-ipo-priced-at-14-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4127","BBP","FHLC","TRXB","BK4588","FWD","IEIH","REDS","FRHC","IPOS","LNGR","BK4585","RSPH","BBC","KCE","JDOC","DARP","SYNB","IBB","XT","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674785642","title":"Teva announces FDA approval for Weltruza","url":"https://stock-news.laohu8.com/highlight/detail?id=2674785642","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674785642?lang=en_us&edition=fundamental","pubTime":"2026-10-09 19:05","pubTimestamp":1791543924,"startTime":"0","endTime":"0","summary":"Teva (TEVA) announced that the FDA has approved Weltruza for extended-release injectable suspension, a new, once-monthly, subcutaneous long-acting ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/teva-announces-fda-approval-for-weltruza-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/teva-announces-fda-approval-for-weltruza-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSCH","LFSC","TEVA","MRNY","GDOC","BK4588","BK4566","BK4007","IYH","XLVX","BBP","BK4596","IDNA","MEDI","TECB","BMED","LABU","NVIB","BK4557","IBB","LU2324357040.USD","FRTY","BK4584","IEIH","SYNB","GNMX","TBXU","RSPH","LU1983299246.USD","PINK","BK4559","BK4585","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119313877","title":"Contec Medical Systems Secures Medical Device Registration Certificate for Color Doppler Ultrasound Diagnostic System","url":"https://stock-news.laohu8.com/highlight/detail?id=1119313877","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119313877?lang=en_us&edition=fundamental","pubTime":"2026-10-09 19:00","pubTimestamp":1791543614,"startTime":"0","endTime":"0","summary":"Contec Medical Systems Co.,Ltd. (300869.SZ) has announced that the company recently obtained a Medical Device Registration Certificate of the People's Republic of China issued by the Hebei Provincial...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["300869","AGNG","HART","MEDX","IEIH","159883","PTH","MDEV","RSPH","BK0251","BK1583","BK1574","GDOC","09996","BK1100","LNGR","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118774782","title":"Citi Lowers Novo Nordisk Price Target to DKK 296: Oral Weight-Loss Pill Sales Outlook Improves, but Margin Growth Remains Weak","url":"https://stock-news.laohu8.com/highlight/detail?id=1118774782","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118774782?lang=en_us&edition=fundamental","pubTime":"2026-10-09 14:30","pubTimestamp":1791527422,"startTime":"0","endTime":"0","summary":"Citi has cut its price target on Danish pharmaceutical company Novo Nordisk from DKK 310 to DKK 296, while maintaining a \"Neutral\" rating.The main reason is that Novo Nordisk expects its profit...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1506573853.SGD","LU2456880835.USD","LU0203345920.USD","LU1366192091.USD","PJP","PINK","MEDI","BK4566","LU1074936037.SGD","LU2125154935.USD","C","LU0310800965.SGD","LU0130102774.USD","LU0320765646.SGD","FTXO","LU2125154778.USD","NVOX","RSPH","LU0052756011.USD","LU2236285917.USD","LU1162221912.USD","TFNS","LU1791807156.HKD","IYH","BK4504","LU1144417596.USD","NVOC","NBDS","LU1244550221.USD","BK4207","LU0098860793.USD","FHLC","LU0128525689.USD","LU1201861249.SGD","LU0314106906.USD","LU2462157665.USD","XLVI","LU1267930227.SGD","CURE","BK4585","LU1244550494.USD","BK4588","FXH","LU0072461881.USD","LU0130517989.USD","IYF","LU0477156953.USD","LU2417539215.USD","BK4534","LU0203347892.USD","LU0980610538.SGD","TRUH","NVOH","LU1244550577.SGD","LU0106831901.USD","BK4559","LU0170899867.USD","LU2360032135.SGD","THNR","LU1668664300.SGD","IE00BSNM7G36.USD","LU0162691827.USD","BGIA","LU0648001328.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674887029","title":"Island Pharmaceuticals Expands Unquoted Employee Options Pool","url":"https://stock-news.laohu8.com/highlight/detail?id=2674887029","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674887029?lang=en_us&edition=fundamental","pubTime":"2026-10-09 11:17","pubTimestamp":1791515857,"startTime":"0","endTime":"0","summary":"The latest update is out from Island Pharmaceuticals Ltd ( ($AU:ILA) ). Island Pharmaceuticals Ltd is an ASX-listed biotechnology company focused o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/island-pharmaceuticals-expands-unquoted-employee-options-pool?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/island-pharmaceuticals-expands-unquoted-employee-options-pool?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SYNB","FHLC","BBP","IEIH","IBB","JDOC","DARP","RSPH","BK4588","XT","AGNG","FWD","BK4585","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674184887","title":"Linical Wins $20 Million U.S. Biotech Order as FDA Environment Normalizes","url":"https://stock-news.laohu8.com/highlight/detail?id=2674184887","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674184887?lang=en_us&edition=fundamental","pubTime":"2026-10-09 10:52","pubTimestamp":1791514334,"startTime":"0","endTime":"0","summary":"Linical Co., Ltd. ( ($JP:2183) ) has issued an update. Linical Co., Ltd. has secured a large new order from a U.S. biotechnology company worth 20.4...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/linical-wins-20-million-u-s-biotech-order-as-fda-environment-normalizes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/linical-wins-20-million-u-s-biotech-order-as-fda-environment-normalizes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","JDOC","RSPH","PBE","BK4581","BBP","BK4588","IEIH","DARP","LNGR","XT","FHLC","IBB","FWD","SYNB","XBIX","AGNG","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674880548","title":"Health Care Down as Michigan Files Suit Against Insurer","url":"https://stock-news.laohu8.com/highlight/detail?id=2674880548","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674880548?lang=en_us&edition=fundamental","pubTime":"2026-10-09 05:28","pubTimestamp":1791494880,"startTime":"0","endTime":"0","summary":"Health-care companies fell amid fears that health insurers would remain in regulatory crosshairs during the election season.Michigan's attorney general filed an antitrust suit against the state's largest health insurer Blue Cross Blue Shield of Michigan, citing monopolistic pricing practices.Among publicly traded health insurers, Humana and UnitedHealth Group lost ground.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU1988902786.USD","PINK","MHIP","UNHG","LU1153585028.USD","SUNH0main","RXL","GDOC","LU0053666078.USD","XBI","FXH","LU0820561909.HKD","IE00B894F039.SGD","LU2954938101.SGD","RSPH","FHLC","LU1057294990.SGD","LU0976567544.SGD","LU1732800096.USD","VHT","IE0002141913.USD","LU0158827781.USD","LU0310800965.SGD","IE00B2B36J28.USD","LU0162691827.USD","IXJ","SGXZ51526630.SGD","RXD","LU0011850046.USD","LABU","XLV","JDOC","LU0097036916.USD","SG9999018857.SGD","IYH","LU0072461881.USD","JHMH","LU0211328371.USD","IHF","HRTS","LU0058720904.USD","CURE","TRUH","UN","UNHU","TMED","UNHW","LU0965509010.AUD","UNH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178666966","title":"Starbucks Explored Acquisition of Chipotle in Bid to Create Restaurant Industry Mega-Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=1178666966","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178666966?lang=en_us&edition=fundamental","pubTime":"2026-10-08 22:20","pubTimestamp":1791469222,"startTime":"0","endTime":"0","summary":"Starbucks held discussions about acquiring Chipotle Mexican Grill, a grand plan that would merge two of America's most recognized consumer brands and, if completed, would rank as the largest merger...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GTPE","RSPH","MNA","SBU","BK4209","SBUX","FFSM","AAUM","XLFI","IYH","BK4585","ACTV","BK4588","PEVC","PRVT","BK4504","LU0882574139.USD","VXF","LU0823411888.USD","PBPH","TMED","UYG","BREW","BK4535","MMID","PSP","IBBQ","CANC","BK4610","DFMC","IEFN","TBXU","PBJ","EATZ","IE00B3T34201.USD","RFG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137044188","title":"Shandong Oriental Ocean's Subsidiary Secures Medical Device Registration Certificate for Water-Soluble Vitamin Assay Kit","url":"https://stock-news.laohu8.com/highlight/detail?id=1137044188","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137044188?lang=en_us&edition=fundamental","pubTime":"2026-10-08 16:48","pubTimestamp":1791449307,"startTime":"0","endTime":"0","summary":"Shandong Oriental Ocean Sci-Tech Co.,Ltd. (002086.SZ) has announced that its subsidiary, Mass Spectrometry Biotechnology Co., Ltd., has received registration approval from the Shandong Provincial...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","BK0046","BK1583","MEDX","LGHT","002086","BK1574","GDOC","PTH","09996","159883","HART","RSPH","AGNG","BK0213","BK0092","MDEV","IEIH","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175454812","title":"Beijing Strong Biotechnologies Secures Medical Device Registration Certificates for Five Products","url":"https://stock-news.laohu8.com/highlight/detail?id=1175454812","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175454812?lang=en_us&edition=fundamental","pubTime":"2026-10-08 16:27","pubTimestamp":1791448021,"startTime":"0","endTime":"0","summary":"Beijing Strong Biotechnologies, Inc. (300406.SZ) has announced that the company and its wholly-owned subsidiary, Beijing Meichuang Xinyue Medical Devices Co., Ltd., recently received Medical Device...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","HART","RSPH","159883","BK1100","BK0028","BK0077","LGHT","AGNG","BK0046","GDOC","PTH","BK1583","MDEV","LNGR","BK0012","09996","300406","BK1574","BK0239","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113468304","title":"Centinel Spine Reports 42% Revenue Surge and Return to Profit as It Pursues U.S. IPO, Testing Valuations for Innovative Medical Devices","url":"https://stock-news.laohu8.com/highlight/detail?id=1113468304","media":"Stock News","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113468304?lang=en_us&edition=fundamental","pubTime":"2026-10-08 14:58","pubTimestamp":1791442703,"startTime":"0","endTime":"0","summary":"Centinel Spine, a well-known American medical device manufacturer, disclosed in its U.S. initial public offering filing on Wednesday local time that its first-half revenue surged 42%. The IPO...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","HART","IEIH","MEDX","MDEV","KCE","BK1574","GDOC","AGNG","FRHC","159883","09996","IPOS","RSPH","LGHT","PTH","LNGR","BK4127","REDS","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673011517","title":"Novartis announces FDA approval of Rhapsido for symptomatic dermographism","url":"https://stock-news.laohu8.com/highlight/detail?id=2673011517","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673011517?lang=en_us&edition=fundamental","pubTime":"2026-10-07 23:50","pubTimestamp":1791388212,"startTime":"0","endTime":"0","summary":"Novartis (NVS) announced that the Food and Drug Administration approved Rhapsido as the first treatment for adults with symptomatic dermographism i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novartis-announces-fda-approval-of-rhapsido-for-symptomatic-dermographism-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novartis-announces-fda-approval-of-rhapsido-for-symptomatic-dermographism-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSCH","MEDX","LU0070302665.USD","XLVX","NVIB","LU0208291251.USD","IE00BJT1NW94.SGD","BMED","LFSC","IYH","LABU","FRTY","BK4585","BK4588","BBP","BK4007","MEDI","IEIH","TECB","GNMX","PINK","BK4578","MRNY","LU0320765489.SGD","IE0002141913.USD","IBB","SYNB","TBXU","GDOC","IDNA","BK4532","MRNX","IE00BFTCPJ56.SGD","IE0009355771.USD","IE00B4R5TH58.HKD","LU0211331839.USD","RSPH","NVS","IE00BJJMRZ35.SGD","PPH","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673118620","title":"Novartis Rhapsido® (remibrutinib) receives FDA approval as first treatment for symptomatic dermographism (SD), expanding its use beyond chronic spontaneous urticaria (CSU)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673118620","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673118620?lang=en_us&edition=fundamental","pubTime":"2026-10-07 23:45","pubTimestamp":1791387900,"startTime":"0","endTime":"0","summary":"In Phase III RemIND trial, twice as many adults taking Rhapsido achieved complete hive resolution by Week 12 vs placebo, with responses seen by Week 21SD is most prevalent type of chronic inducible ur","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/07/3376686/0/en/novartis-rhapsido-remibrutinib-receives-fda-approval-as-first-treatment-for-symptomatic-dermographism-sd-expanding-its-use-beyond-chronic-spontaneous-urticaria-csu.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IAI","LU1064131342.USD","LU1720051108.HKD","LU0210528500.USD","LU1668664300.SGD","LU0528227936.USD","LU0267386448.USD","MEDI","PINK","LU2089284900.SGD","PSCH","KBWB","LU2357305700.SGD","LU2487616109.SGD","SD","TBXU","TECB","BK4581","LFSC","MRNX","LABU","BK4585","LU1720051017.SGD","LU0390134368.USD","NVIB","FRTY","IBB","BK4504","LU0912757837.SGD","BBP","LU1791710582.SGD","IEIH","LU2028103732.USD","BMED","MRNY","XLVX","LU1244550221.USD","LU0795875169.SGD","SYNB","RSPH","LU2023251221.USD","GDOC","LU2264538146.SGD","IE00BZ1G4Q59.USD","LU0106831901.USD","IE00B3S45H60.SGD","LU1989772840.SGD","IYH","GNMX","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673931066","title":"Adherium Secures Non-Dilutive AUD$700,000 Loan to Support Working Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2673931066","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673931066?lang=en_us&edition=fundamental","pubTime":"2026-10-07 05:59","pubTimestamp":1791323947,"startTime":"0","endTime":"0","summary":"Adherium Ltd. ( ($AU:ADR) ) has issued an announcement. Adherium Limited, a global provider of connected respiratory medical devices and digital he...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adherium-secures-non-dilutive-aud700000-loan-to-support-working-capital?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adherium-secures-non-dilutive-aud700000-loan-to-support-working-capital?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SAPH","GDOC","AADR","MEDI","HART","AGNG","APIE","DINT","CURE","ARMH","IEHS","IBRN","MDTX","XT","PINK","CVY","LNGR","CROC","MDEV","BMED","RSPH","DIVL","FHLC","HRTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672116477","title":"Press Release: Celcuity Appoints David Gryska to Its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672116477","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672116477?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:00","pubTimestamp":1790942400,"startTime":"0","endTime":"0","summary":"MINNEAPOLIS, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a biotechnology company focused on developing and commercializing targeted therapies for the treatment of multiple solid tu","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4604","BK4139","03160","IDNA","MEDX","BK4555","TM","BK4588","CELC","BBP","SYNB","NVIB","HYLG","IBB","IEIH","BK4585","BK4099","RSPH","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672163957","title":"Abogen announces licensing, option agreement with Novartis","url":"https://stock-news.laohu8.com/highlight/detail?id=2672163957","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672163957?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:10","pubTimestamp":1790935812,"startTime":"0","endTime":"0","summary":"Abogen Biosciences, a clinical-stage biotechnology group pioneering RNA innovation, announced that it has entered into a licensing and option agree...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abogen-announces-licensing-option-agreement-with-novartis-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abogen-announces-licensing-option-agreement-with-novartis-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC","RSPH","BBP","SYNB","RNA","FHLC","FWD","IE0009354923.USD","BK4505","JDOC","AGNG","XT","DARP","BK4139","LNGR","BK4585","IBB","BK4588","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672629967","title":"Nanobiotix taps veteran biotech CFO Arnd Christ to steer next growth phase","url":"https://stock-news.laohu8.com/highlight/detail?id=2672629967","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672629967?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:37","pubTimestamp":1790887025,"startTime":"0","endTime":"0","summary":"The latest update is out from Nanobiotix ( ($FR:NANO) ). Nanobiotix is a late‑stage French biotechnology company developing physics‑based therapeut...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nanobiotix-taps-veteran-biotech-cfo-arnd-christ-to-steer-next-growth-phase?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nanobiotix-taps-veteran-biotech-cfo-arnd-christ-to-steer-next-growth-phase?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","BK4588","XT","AGNG","FWD","NVIB","SYNB","BK4585","IEIH","JDOC","NANO","XBIX","FHLC","IBB","BBP","LNGR","DARP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672632267","title":"Oxford BioDynamics Extends Vulpes Payment Deadline in £9.15m Placing","url":"https://stock-news.laohu8.com/highlight/detail?id=2672632267","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672632267?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:12","pubTimestamp":1790867579,"startTime":"0","endTime":"0","summary":"Oxford BioDynamics ( ($GB:OBD) ) has provided an announcement. Oxford BioDynamics Plc, a 3D genomics-focused biotechnology company listed on AIM, p...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oxford-biodynamics-extends-vulpes-payment-deadline-in-9-15m-placing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oxford-biodynamics-extends-vulpes-payment-deadline-in-9-15m-placing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","OXM","FHLC","BK4585","BK4202","FWD","BK4588","TARK","BBP","IEIH","RSPH","IBB","DARP","GNOM","LNGR","SYNB","JDOC","XT","AGNG","BMED","GNMX","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672875083","title":"Outlook submits HCPCS Level II application to CMS for J-code for LYTENAVA","url":"https://stock-news.laohu8.com/highlight/detail?id=2672875083","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672875083?lang=en_us&edition=fundamental","pubTime":"2026-10-01 21:10","pubTimestamp":1790860239,"startTime":"0","endTime":"0","summary":"Outlook Therapeutics (OTLK) announced that it has submitted an application to the Centers for Medicare & Medicaid Services, CMS, requesting a perma...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/outlook-submits-hcpcs-level-ii-application-to-cms-for-j-code-for-lytenava-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/outlook-submits-hcpcs-level-ii-application-to-cms-for-j-code-for-lytenava-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","LNGR","OTLK","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171935778","title":"Paramount Names Kreiz as Co-CEO as Warner Bros. Deal Nears Completion","url":"https://stock-news.laohu8.com/highlight/detail?id=1171935778","media":"Deep News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171935778?lang=en_us&edition=fundamental","pubTime":"2026-10-01 07:10","pubTimestamp":1790809815,"startTime":"0","endTime":"0","summary":"David Ellison of Paramount Skydance Corp. said that former Mattel Inc. CEO Ynon Kreiz will become co-CEO of the combined company once the pending $110 billion acquisition of Warner Bros. Discovery...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFMC","IYH","TBXU","MMID","ACTV","PSP","PRVT","UYG","PEVC","RFG","BK4585","IEFN","BK4588","MNA","FFSM","RSPH","BK4108","PBPH","BK4561","XLFI","AAUM","IBBQ","CANC","VXF","BK4571","GTPE","TMED","WMG"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}